Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dermal Priming in Enhancing Vaccine Immunogenicity
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Summary
Experimental medicine study in patients receiving B cell depletion therapy administering an immune challenge with seasonal influenza vaccination with/without concurrent administration of topical imiquimod (TLR7 agonist) aiming to determine proof of concept that local dermal immune priming alters physiological parameters following immunisation in this context.
Official title: Understanding the Impact of Local Dermal Priming in Enhancing Vaccine Immunogenicity in Patients Receiving B Cell Depleting Immunosuppression
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2025-12-15
Completion Date
2027-06-30
Last Updated
2026-11-09
Healthy Volunteers
No
Interventions
Imiquimod (topical use)
Topical application at site of influenza vaccine administration
Aqueous cream
Topical aqueous cream
Locations (1)
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom